Jim Tananbaum is the talented CEO of Foresite Capital since he founded it in 2011. Foresite Capital is a renowned healthcare private equity firm that specializes in identifying healthcare leaders and helping them to grow the company towards profitability through disseminating networks, capital, and information. Jim has also founded two companies, including Theravance, Inc. and GelTex Pharmaceuticals. He has led many healthcare investment practices, including Jazz Pharmaceuticals, Amira Pharmaceuticals, and Amerigroup.
Jim’s passion of marrying computer science and interdisciplinary hard sciences with healthcare began when he was still in high school. He has had robust and long-term relationships with many academicians, for instance, his collaborators Bob Gunderson, George Whitesides, Rick Levin mentored him.
The Inception of Foresite Capital
Jim revealed that he founded Foresite Capital based on his experience as an investment strategist and healthcare entrepreneur for more than 25 years. He mentioned that the idea of inaugurating the company came from acknowledging that innovative healthcare products required more capital and time. Jim cited that the company supplied networks and capital to emerging leaders to help them achieve their success. He also mentioned that Foresite Capital had invested in healthcare companies in medical services and biopharmaceuticals.
Jim cited that actualizing ideas into reality not only involved capital but also required engaging leaders who were smart, effective, and persistent in healthcare. Jim acknowledged that he was inspired by how entrepreneurs applied the science behind healthcare innovation to solve problems in the health industry. Jim cited that he has managed to grow his business, Foresite Capital, through critically identifying the best people to synergize with the company’s expertise and determine where the puck is going.
A Closer Focus on Jim Tananbaum
Jim Tananbaum is the acclaimed founder of Foresite Capital, a leading healthcare private equity firm. He serves as the CEO of the company and has led investments in 21 healthcare companies such as Jazz Pharmaceuticals, Amira Pharmaceutical, and Amerigroup. Jim has also founded GelTex Pharmaceutical and Theravance, Inc. where he held managerial positions.
Jim was a student at Harvard Medical School where he acquired an M.D. He also got an M.B.A from the distinguished Harvard Business School. Jim graduated from Massachusetts Institute of Technology with an M.S. in Information theory and a BS, BSEE from Yale University. More details can be found on Crunchbase.